These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26183291)

  • 1. Novel perspectives in cancer therapy: Targeting ion channels.
    Arcangeli A; Becchetti A
    Drug Resist Updat; 2015; 21-22():11-9. PubMed ID: 26183291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy.
    Arcangeli A; Crociani O; Lastraioli E; Masi A; Pillozzi S; Becchetti A
    Curr Med Chem; 2009; 16(1):66-93. PubMed ID: 19149563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Trends in Cancer Therapy: Targeting Ion Channels and Transporters.
    Arcangeli A; Becchetti A
    Pharmaceuticals (Basel); 2010 Apr; 3(4):1202-1224. PubMed ID: 27713296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and functional interaction between integrins and hERG1 channels in cancer cells.
    Pillozzi S; Arcangeli A
    Adv Exp Med Biol; 2010; 674():55-67. PubMed ID: 20549940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular genetics in the hereditary form of long QT syndrome].
    Georgijević Milić L
    Med Pregl; 2000; 53(1-2):51-4. PubMed ID: 10953551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K(+) channels as therapeutic targets in oncology.
    Stühmer W; Pardo LA
    Future Med Chem; 2010 May; 2(5):745-55. PubMed ID: 21426201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTS techniques to investigate the potential effects of compounds on cardiac ion channels at early-stages of drug discovery.
    Netzer R; Bischoff U; Ebneth A
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):462-9. PubMed ID: 12951809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ion channels in gastrointestinal cancer.
    Anderson KJ; Cormier RT; Scott PM
    World J Gastroenterol; 2019 Oct; 25(38):5732-5772. PubMed ID: 31636470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological effects of the anti-cancer drug lapatinib on cardiac repolarization.
    Lee HA; Kim EJ; Hyun SA; Park SG; Kim KS
    Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):614-8. PubMed ID: 20406211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological targeting of ion channels for cancer therapy: In vivo evidences.
    Leanza L; Managò A; Zoratti M; Gulbins E; Szabo I
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt B):1385-97. PubMed ID: 26658642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hERG1 potassium channel in cancer cells: a tool to reprogram immortality.
    Gentile S
    Eur Biophys J; 2016 Oct; 45(7):649-655. PubMed ID: 27649700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channels: novel emerging biomarkers and targets for therapy in cancer.
    D'Amico M; Gasparoli L; Arcangeli A
    Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):53-65. PubMed ID: 22574647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting ion channels for new strategies in cancer diagnosis and therapy.
    Conti M
    Curr Clin Pharmacol; 2007 May; 2(2):135-44. PubMed ID: 18690861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ion channels in leukemias: a new challenge for treatment.
    Arcangeli A; Pillozzi S; Becchetti A
    Curr Med Chem; 2012; 19(5):683-96. PubMed ID: 22204341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer: Ion channel and aquaporin expression as novel targets of clinical potential.
    Frede J; Fraser SP; Oskay-Özcelik G; Hong Y; Ioana Braicu E; Sehouli J; Gabra H; Djamgoz MB
    Eur J Cancer; 2013 Jul; 49(10):2331-44. PubMed ID: 23683551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLC-3 channels in cancer (review).
    Hong S; Bi M; Wang L; Kang Z; Ling L; Zhao C
    Oncol Rep; 2015 Feb; 33(2):507-14. PubMed ID: 25421907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltage-gated sodium channels: therapeutic targets for pain.
    Dib-Hajj SD; Black JA; Waxman SG
    Pain Med; 2009 Oct; 10(7):1260-9. PubMed ID: 19818036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
    Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
    Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Mitochondrial Ion Channels to Fight Cancer.
    Bachmann M; Costa R; Peruzzo R; Prosdocimi E; Checchetto V; Leanza L
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.